Cargando…
Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?
Several clinical trials to establish standard treatment modality for ovarian cancers included a high abundance of patients with serous histologic tumors, which were quite sensitive to platinum-based chemotherapy. On the other hand, ovarian tumor with rare histologic subtypes such as clear cell or mu...
Autores principales: | Takano, Masashi, Tsuda, Hiroshi, Sugiyama, Toru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405444/ https://www.ncbi.nlm.nih.gov/pubmed/22655678 http://dx.doi.org/10.1186/1756-9966-31-53 |
Ejemplares similares
-
Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
por: Mabuchi, Seiji, et al.
Publicado: (2016) -
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
por: Takano, M, et al.
Publicado: (2006) -
UGT1A1 polymorphisms in cancer: impact on irinotecan treatment
por: Takano, Masashi, et al.
Publicado: (2017) -
Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review)
por: UEKURI, CHIHARU, et al.
Publicado: (2013) -
Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review
por: Miyamoto, Morikazu, et al.
Publicado: (2013)